Farhad Amiri, PhD, FAHA

Farhad has over 15 years’ experience working for the pharmaceutical business in roles involving nonclinical to early clinical studies and strategic consulting, some of which were as a client. His responsibilities have spanned the spectrum from early efficacy studies to IND-and NDA-enabling nonclinical studies for US, Canadian and International clients. 

While Farhad has certainly done his share of interpreting study data and publishing results, his passion has centred on providing his clients the most realistic and fastest strategies in accomplishing their IND- or NDA-target dates.

He has also been a project manager on several IND (or CTA) and NDA-enabling studies for NCE and large molecules for clients, ranging from small to large pharma companies.

Work experience

Prior to joining Parexel, Farhad was both on the client side (small to large pharma) and on the nonclinical CRO side. Previous experience includes conducting, oversight management of nonclinical programs and strategic development of nonclinical programs for small and large molecules administered by multiple routes in multiple species.

Education

Farhad holds a Ph.D. in Biomedical Sciences and a B.Sc. in Biological Sciences, specialization in Microbiology & Immunology both from of the University of Montreal, Canada. He is also a Fellow of the American Heart Association.